Abstract
Background
There is extensive focus on the rising costs of healthcare. However, for patients undergoing cancer treatment, there are additional personal costs, which are poorly characterised.
Aim
To qualify indirect costs during anti-cancer therapy in a designated Irish cancer centre.
Methods
An anonymous questionnaire collected demographic data, current work practice, and personal expenditure on regular and non-regular indirect costs during treatment. Differences between groups of interest were compared using the Mann–Whitney U test.
Results
In total, there were 151 responders of median age 58 years; 60 % were female and 74 % were not working. Breast cancer (29 %) was the most frequent diagnosis. Indirect costs totalled a median of €1138 (range €21.60–€7089.84) per patient, with median monthly outgoings of €354. The greatest median monthly costs were hair accessories (€400), transportation (€65), and complementary therapies (€55). The majority (74 %) of patients used a car and median monthly fuel expenditure was €31 (range €1.44–€463.32). Women spent more money during treatment (€1617) than men (€974, p = 0.00128). In addition, median monthly expenditure was greater for those less than 50 years old (€1621 vs €1105; p = 0.04236), those who lived greater than 25 km away (€2015 vs €1078; p = 0.00008) and those without a medical card (€2023 vs €961; p = 0.00024).
Conclusion
This study highlights the need for greater awareness of indirect expenditures associated with systemic anti-cancer therapy in Ireland.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gordon L, Scuffham P, Hayes S et al (2007) Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology 16:1130–1139
Arndt V, Merx H, Stegmaier C et al (2004) Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 22:4829–4836
Arndt V, Merx H, Stegmaier C et al (2005) Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 23:4945–4953
Moore KA (1999) Breast cancer patients’ out-of-pocket expenses. Cancer Nurs 22:389–396
Pearce S, Kelly D, Stevens W (2001) “More than just money”—widening the understanding of the costs involved in cancer care. J Adv Nurs 33(3):371–379
Longo CJ, Fitch M, Deber RB et al (2006) Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer 14:1077–1085
Irish Employees’ Motoring/Bicycle Expenses-IT51 (2016) http://www.revenue.ie/en/tax/it/leaflets/it51.html. Accessed 13 Jul 2016
L Sharp, A Timmons (2010) The financial impact of a cancer diagnosis. http://hse.openrepository.com/hse/handle/10147/188292. Accessed 13 Jul 2016
Irish Cancer Society (2016) The real cost of cancer. Research conducted by Millward Brown 2015. http://www.cancer.ie/sites/default/files/content-attachments/the_real_cost_of_cancer_report_final.pdf. Accessed 13 Jul 2016
Meropol NJ, Schrag D, Smith TJ et al (2009) American society of clinical oncology guidance statement: the cost of cancer care. J Clin Oncol 27(23):3868–3874
Macmillan (2012) Cost of cancer campaign. http://www.macmillan.org.uk/documents/getinvolved/campaigns/costofcancer/thecostofcancercampaignreport.pdf. Accessed 13 Jul 2016
Acknowledgments
The authors wish to thank the patients and their families for taking part in this research and completing the questionnaire.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study has no funding to declare.
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Collins, D.C., Coghlan, M., Hennessy, B.T. et al. The impact of outpatient systemic anti-cancer treatment on patient costs and work practices. Ir J Med Sci 186, 81–87 (2017). https://doi.org/10.1007/s11845-016-1483-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-016-1483-x